Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 AUD | 0.00% | +2.44% | -58.00% |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sleep Related Disorder Devices
100.0
%
| 73 | 100.0 % | 84 | 100.0 % | +15.20% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
56.6
%
| 42 | 58.5 % | 47 | 56.6 % | +11.46% |
North America
36.1
%
| 25 | 34.0 % | 30 | 36.1 % | +22.18% |
Asia Pacific
7.3
%
| 5 | 7.5 % | 6 | 7.3 % | +12.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 20-08-23 | |
Karen Borg
CEO | Chief Executive Officer | - | 20-11-25 |
Darren Collins
DFI | Director of Finance/CFO | - | 23-07-31 |
David Lewis
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-31 |
Arlene Graham
HRO | Human Resources Officer | - | 21-03-31 |
- | - | ||
Jarred Shein
PRN | Corporate Officer/Principal | - | 21-06-30 |
Mark Harding
SAM | Sales & Marketing | - | 19-06-30 |
Corporate Officer/Principal | - | 03-12-31 | |
Corporate Secretary | - | 94-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hamish Corlett
BRD | Director/Board Member | - | 18-04-30 |
Guy Russo
CHM | Chairman | 65 | 20-08-23 |
Karen Borg
CEO | Chief Executive Officer | - | 20-11-25 |
Michael Gordon
BRD | Director/Board Member | - | 20-08-23 |
Chief Executive Officer | - | 20-08-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 216,107,630 | 189,259,553 ( 87.58 %) | 0 | 87.58 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-58.00% | 18.59M | |
-2.20% | 185B | |
-3.32% | 105B | |
-4.65% | 66.59B | |
+1.66% | 54.66B | |
+17.25% | 47.78B | |
+4.06% | 41.26B | |
+3.07% | 26.95B | |
+2.19% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- SOM Stock
- Company SomnoMed Limited